Clinical Trial Update: Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea [Phase 2]

View source ↗

Summary

Phase 2 trial update showing completion of a toxin-based treatment for sialorrhea in amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Sialorrhea, Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED